Association of HLA-DRB1 with viral load and immune response to Epstein Barr virus in adult and pediatric Systemic Lupus Erythematosus patients.

Title – Table - Supplemental material for “Association of HLA-DRB1 with viral load and immune response to Epstein Barr virus in adult and pediatric Systemic Lupus Erythematosus patients”; Description – “Supplemental material, tables, for “Association of HLA-DRB1 with viral load and immune response to Epstein Barr virus in adult and pediatric Systemic Lupus Erythematosus patients” by Das P, Minz R W, Saikia B, Sharma A, Anand S, Singh H, Singh S in LupusTable 1 Caption: aSee reference: 11,15–17, bSLE: total SLE patients, cHC: total healthy controls; Pos: Positive; Neg: Negative; EBV: Epstein-Barr Virus; VCA: viral capsid antigen; EBNA-1: EB nuclear antigen-1; p22: viral capsid antigen; EA-D: viral early antigen diffuse; n: number of samples, SLE: systemic lupus erythematosus; aSLE:adult SLE, pSLE: pediatric SLE, aHC: adult healthy controls, pHC: pediatric healthy controls; Acute infection is described as anti-VCA IgM/IgG positive but anti-EBNA-1 IgG negative; past infection is described as anti-VCA IgG and anti-EBNA-1 IgG positive but anti-VCA IgM negative and viral reactivation is described as positive for anti-EBNA-1 IgG and anti-EA-D IgG.Table 2 caption: EBV: Epstein Barr Virus; VCA: viral capsid antigen; EBNA-1: EB nuclear antigen; p22: capsid antigen; EA-D: early antigen diffuse; HLA: human leukocyte antigen; aSLE: adult SLE; pSLE: pediatric SLE; n: sample size for calculation of genotype frequency; 2n: sample size for calculation of allele frequency, because each individual contributes two separate alleles